Power et al: Incidence and severity of short‐term incisional complications after intraoperative local infiltration of liposomal bupivacaine in dogs
Veterinary Surgery 4, 2022

🔍 Key Findings

  • Overall complication rate was 19.7% (43/218), with most being mild (CSS 1).
  • Soft tissue procedures had higher complication rates (26%) than orthopedic procedures (11.6%) (P < 0.01).
  • No difference in complication rates between clean, clean-contaminated, and contaminated wounds (P = 0.55).
  • No difference in complication rates between labeled use (CCL surgery) and off-label orthopedic procedures (P = 0.21).
  • Majority of complications (63%) were mild, resolving without intervention or with topical therapy.
  • Severe complications requiring revision surgery were rare (2.3%) and occurred mainly in soft-tissue surgeries.
  • Most common complications included SSI (25.6%), dehiscence (16.3%), and seroma (14%).
  • Liposomal bupivacaine appears safe for use in broader orthopedic procedures beyond current labeling.

Simini Surgery Review Podcast

How critical is this paper for crushing the Boards?

🚨 Must-know. I’d bet on seeing this.

📚 Useful background, not must-know.

💤 Skip it. Doubt it’ll ever show up.

Thanks for the feedback!
We'll keep fine-tuning the articles vault.
Oops — didn’t go through.
Mind trying that again?